Penumbra

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.

CEO

Adam Elsesser

CEOAdam Elsesser

Employees

4,500

Employees4,500

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

2004

Founded2004

Employees

4,500

Employees4,500

PEN Key Statistics

Market cap

10.54B

Market cap10.54B

Price-Earnings ratio

72.31

Price-Earnings ratio72.31

Dividend yield

—

Dividend yield—

Average volume

485.32K

Average volume485.32K

High today

$275.69

High today$275.69

Low today

$269.68

Low today$269.68

Open price

$274.68

Open price$274.68

Volume

80.73K

Volume80.73K

52 Week high

$310.00

52 Week high$310.00

52 Week low

$184.80

52 Week low$184.80

PEN News

Simply Wall St 2d

What Penumbra's Recent Stock Dip Amid Rate Cut Hopes Means For Shareholders

In the past week, several healthcare stocks including Penumbra declined after markets pulled back despite a softer-than-expected August U.S. Producer Price Inde...

TipRanks 5d

Positive Outlook on Penumbra’s Stock Driven by Ruby XL’s Market Impact and Efficiency Gains

Bank of America Securities analyst Travis Steed maintained a Buy rating on Penumbra yesterday and set a price target of $320.00. Elevate Your Investing Strategy...

Analyst ratings

77%

of 22 ratings

Buy

77.3%

Hold

18.2%

Sell

4.5%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.